Home/Filings/4/0001144204-17-005185
4//SEC Filing

Caladrius Biosciences, Inc. 4

Accession 0001144204-17-005185

$LSTACIK 0000320017operating

Filed

Jan 30, 7:00 PM ET

Accepted

Jan 31, 6:51 PM ET

Size

9.4 KB

Accession

0001144204-17-005185

Insider Transaction Report

Form 4
Period: 2017-01-09
Wei Eric
Director
Transactions
  • Award

    Options to Purchase Common Stock

    2017-01-09+2,7502,750 total
    Exercise: $3.54From: 2018-01-09Exp: 2027-01-09Common Stock (2,750 underlying)
  • Award

    Common Stock

    2017-01-09+1,6504,300 total
Holdings
  • Common Stock

    (indirect: See Footnote)
    187,223
Footnotes (4)
  • [F1]Represents 1,650 shares of restricted stock granted under the Issuer's 2015 Equity Compensation Plan that will vest on January 9, 2018.
  • [F2]Includes 2,775 shares of unvested restricted stock granted under the Issuer's compensation plans.
  • [F3]186,023 shares of Common Stock of the Issuer are held by RimAsia Capital Partners L.P., a Cayman Islands exempted limited partnership ("RimAsia LP"), and 1,200 shares of Common Stock of the Issuer are held by RimAsia Capital Partners Manager, Ltd., a Cayman Islands exempted company ("RimAsia Manager").
  • [F4]RimAsia Capital Partners GP, L.P., a Cayman Islands exempted limited partnership ("RimAsia GP"), is the general partner of RimAsia LP. RimAsia Manager is the Fund Manager of RimAsia GP and the Manager of RimAsia LP. Mr. Wei is the managing partner of RimAsia LP, an indirect partner of RimAsia GP, a director of RimAsia Capital Partners GP, Ltd. and a director of RimAsia Manager. As a result, Mr. Wei may be deemed to have sole power to vote certain of the securities held by RimAsia LP and RimAsia Manager. Mr. Wei disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein, and the inclusion of these securities shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 of the Securities Exchange Act or for any other purpose..

Issuer

Caladrius Biosciences, Inc.

CIK 0000320017

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000320017

Filing Metadata

Form type
4
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 6:51 PM ET
Size
9.4 KB